Watch replays of the main stage programming from the SOSV Climate Tech Summit (Nov. 5-6)

Giving people more time.

GET CONNECTED
chronosdx.co.uk

Team

James Tyrrell

Co-Founder

Ella Mi

Co-Founder

Chronos DX

Company details

ChronosDx has developed an ultrasensitive and scalable bioassay technology for early disease detection, based on proprietary organic semiconductor technology. Their sensors have achieved world leading attomolar sensitivity, 100,000x superior to state-of-the-art immunoassay, enabling them to pick up diseases like cancer in its early stages when it is undetectable by other technologies.

Female FoundersHuman HealthTherapeuticsUnited KingdomPre-SeedHealthcareHuman HealthHAX 2022

Get In Touch with Chronos DX

Please tell us a little bit about yourself and why you'd like to get connected. Chronos DX + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More